Cite
MLA Citation
Samuel Rosner et al.. “Response after treatment with pembrolizumab in a patient with myelophthisis due to melanoma: the role of checkpoint inhibition in the bone.” Journal for immunotherapy of cancer, vol. 5, no. 1, 2017, p. . http://access.bl.uk/ark:/81055/vdc_100144253069.0x000014